SV Stroke Management

Proportions.JPG (67009 bytes)Scientia Veritas, L.L.P.


 


About Us        Healthcare        Toxicology        Company News        Contact Us        Search

  ScientiaVision Reports            Stroke Management Markets and Strategies

Retrieve Order

About Us

Toxicology

Company News

Healthcare

ScientiaVision

Stroke Management

TOC-LOEs

Coming Soon

Search

Advanced Search

Contact Us



Secure transactions provided by LinkPoint International.

Stroke Management Markets and STRATEGIes

Published April 2003

 


Download Table of Contents and List of Exhibits FREE

Download Update 2 to
Stroke Management Markets and Strategies FREE!

Update 2 to Stroke Management Markets and Strategies became available February 4, 2005.  The updates includes new product approvals, mergers and acquisitions, and other events affecting the industry in question.

 

New, lower prices:  Download the entire report for $450; 
download any chapter for $150.

 

 

Stroke is the third-leading cause of death in the United States—behind cancer and heart disease—and it is the leading cause of serious, long-term disability.  Research conducted during the 1990s increased understanding of the workings of the brain and increased understanding of how disease affects the brain.  Stroke management is still in the infant stages of development, and it is expected that there will be significant breakthroughs in all facets of stroke management.

This stroke management report is designed to present the most up-to-date information on the entire stroke market.  The report concentrates on the following areas:

  • Management of stroke, including stroke-related costs, education and training, treatment guidelines, and patient outcomes research studies;

  • Diagnosis of stroke, including early diagnosis, diagnostic tools in use, research and development, and procedure volumes and reimbursements;

  • Pharmaceutical products, including prevention, early intervention, treatment, market forecasts, and market shares;

  • Stroke treatment devices, including catheter-based products (balloons, coils, stents, PVA, and glues), microcatheters, guidewires, and aneurysm clips, with procedure volumes, market forecasts, and market shares; 

  • Surgical interventions for stroke, including carotid endarterectomy and extracranial/intracranial bypass, and procedure volumes and reimbursements; and

  • Analysis of the current and future stroke management markets, including historical market size for the years 1996 through 2000, the base year 2001, and future market sizes for the years 2002 through 2006.

The methodology employed in this report includes extensive use of primary interviews with senior management from stroke management pharmaceutical, stroke device, and research-based companies.  Background information was obtained from a comprehensive search of published literature, reports, and surveys from various government, business, medical trade, and international journals.  Key information from published literature was used as a basis for interviews with over 75 industry executives and product managers, who were asked to validate the information and provide their expert opinions on current and future trends in the field of stroke management.  Interviews were also used to confirm and/or adjust market size, market shares, and projected market activities.

All market data pertain to the United States market at the manufacturers level unless otherwise noted (e.g., reimbursements) and are expressed in current U.S. dollars.  The base year for data was 2001; historical data are provided for years 1996 through 2000; and forecast data are provided for 2002 through 2006.  Market shares are provided for each market segment for the 2001 base year.  

(Note:  Although all industry activities and competitor information is current as of April 2003, the base year for market figures and competitor market shares is 2001 due to the delay in availability of mortality figures, procedure volume information, and other data needed to calculate the stroke portion of sales and procedures.  All market information specifically characterizes the stroke portion of sales, procedure volumes, and reimbursements.)

Chapter 1:  Executive Summary

Chapter 2:  Introduction to Stroke and Stroke Management

Chapter 3:  Issues and Trends

Chapter 4:  Stroke Diagnostics

Chapter 5:  Stroke Pharmaceuticals

Chapter 6:  Stroke Prevention and Treatment Devices

Chapter 7:  Surgical Interventions for Stroke

Chapter 8:  Market Summary

Chapter 9:  Corporate Profiles

Appendix A:  Company Names and Addresses

 

 

Download Adobe Acrobat Reader 5.0


 

Full reports are available in file download, CD, and printed copy formats, and purchase of a full report includes two updates for that industry.  The updates include new product approvals, mergers and acquisitions, and other events affecting the industry in question.

(Please specify in the special instructions whether you prefer CD in Windows or Mac platform.)

 

File Download

SV101Tot

The Stroke Management Markets and Strategies report covers types of stroke; stroke progression; stroke incidence, incidence rate, and mortality; aging of the population and demographics; education and stroke prevention; stroke units and patient outcomes; costs and reimbursement; cerebral angiography, computed tomography (CT), magnetic resonance angiography (MRA), magnetic resonance imaging (MRI), positron emission tomography (PET), and ultrasound use in stroke diagnosis; anticoagulants, antiarrhythmics, antihypertensives, statins, neuroprotectants, thrombolytics, and drugs in Research and Development; catheter-delivered devices (balloons, coils, stents, polyvinyl alcohol, and acrylic-based glues), microcatheters, guidewires and accessories, aneurysm clips, and other devices in R&D; carotid endarterectomy, extracranial/intracranial bypass, stereotactic microsurgery, and stereotactic radiosurgery. Companies profiled in Chapter 9 include Aesculap, Bayer, Boston Scientific, Bristol-Myers Squibb, Cook, Cordis, Genentech, Guidant, Medtronic, and Roche. Market figures and, where applicable, procedure volumes, are included for diagnostics, pharmaceuticals, devices, and surgical intervention for 1996-2006. 
345 pages, 144 Exhibits.

Price: $450.00  (New, low price!)

Format
File Download

Quantity:


Email a Friend

 

Hard Copy

SV101HCStroke Cover Page.JPG (71099 bytes)

Price: $475.00   (New, low price!)
Stroke CD Label.JPG (31590 bytes)

Format
CD, Mac
CD, Windows
Printed Copy

Quantity:


Email a Friend

 

File Download Plus Hard Copy

SV101TotFilewHC

Stroke Management Markets and Strategies, Full Report File Download plus choice of printed copy or CD.   Specify in special instructions whether you request printed copy, Windows CD, or Mac CD.

Price: $500.00  (New, low price!)

Format
File Download plus Hard Copy
(Specify whether printed copy, Windows CD, or Mac CD)

Quantity:


Email a Friend

 

Individual chapter Downloads

SV101Ch1:  Stroke Management Markets and Strategies, Ch 1: Executive Summary, File Download

Chapter 1: Executive Summary contains market figures for 1996, 2001, and 2006 for stroke diagnosis, pharmaceuticals, devices, and surgical interventions. Also presents key demographic and industry issues and trends. 9 exhibits.

Price: $150.00

Format
File Download

Quantity:


Email a Friend

 

SV101Ch2:  Stroke Management Markets and Strategies, Ch 2: Introduction, File Download

Chapter 2: Introduction to Stroke and Stroke Management contains information on types of stroke; stroke progression; stroke incidence, incidence rate, and mortality. 17 exhibits.

Price: $150.00

Format
File Download

Quantity:


Email a Friend

 

SV101Ch3:  Stroke Management Markets and Strategies, Ch 3: Issues and Trends, File Download

Chapter 3: Issues and Trends in Stroke Management focuses on aging of the population and demographics, education and stroke prevention, stroke units and patient outcomes, and costs and reimbursement. 42 exhibits.

Price: $150.00

Format
File Download

Quantity:


Email a Friend

 

SV101Ch4:  Stroke Management Markets and Strategies, Ch 4: Diagnostics, File Download

Chapter 4: Stroke Diagnostics, from the Stroke Management Markets and Strategies report, describes cerebral angiography, computed tomography (CT), magnetic resonance angiography (MRA), magnetic resonance imaging (MRI), positron emission tomography (PET), and ultrasound use in stroke diagnosis. This chapter provides procedure volumes and reimbursements for 1996-2006. 22 exhibits.

Price: $150.00

Format
File Download

Quantity:


Email a Friend

 

SV101Ch5:  Stroke Management Markets and Strategies, Ch 5: Pharmaceuticals, File Download

Chapter 5: Stroke Pharmaceuticals, from the Stroke Management Markets and Strategies report, covers both stroke prevention and stroke treatment drugs. Products include anticoagulants, antiarrhythmics, antihypertensives, statins, neuroprotectants, thrombolytics, and drugs in R&D. This chapter provides market size for 1996-2006, as well as competitor market shares. 11 exhibits.

Price: $150.00

Format
File Download

Quantity:


Email a Friend

 

SV101Ch6:  Stroke Management Markets and Strategies, Ch 6: Devices, File Download

Chapter 6: Stroke Prevention and Treatment Devices covers catheter-delivered devices (balloons, coils, stents, polyvinyl alcohol, and acrylic-based glues), microcatheters, guidewires and accessories, aneurysm clips, and products in research and development. This chapter includes procedure volumes and market sizes for 1996-2006, as well as competitor market shares. 34 exhibits.

Price: $150.00

Format
File Download

Quantity:           


Email a Friend

 

SV101Ch7:  Stroke Management Markets and Strategies, Ch 7: Surgical Interventions, File Download

Chapter 7: Surgical Interventions for Stroke describes carotid endarterectomy, extracranial/intracranial bypass, stereotactic microsurgery, and stereotactic radiosurgery. Procedural volumes and reimbursements are provided for 1996-2006. 4 exhibits.

Price: $150.00

Format
File Download

Quantity:


Email a Friend

 

SV101Ch8:  Stroke Management Markets and Strategies, Ch 8: Market Summary, File Download

Chapter 8: Market Summary provides a summary of the stroke diagnostics, pharmaceuticals, devices, and surgical interventions markets. Complete markets for 1996-2006 for the combined markets and all categories are presented. 7 exhibits.

Price: $150.00

Format
File Download

Quantity:


Email a Friend

 

SV101Ch9:  Stroke Management Markets and Strategies, Ch 9: Corporate Profiles, File Download

Chapter 9: Corporate Profiles provides history and operations, stroke products, financial information, research and development activities, and corporate strategies for each company. Companies covered include Aesculap, Bayer, Boston Scientific, Bristol-Myers Squibb, Cook, Cordis, Genentech, Guidant, Medtronic, and Roche.

Price: $150.00

Format
File Download

Quantity:


Email a Friend

 

SV101App:  Stroke Management Markets and Strategies, Appendix: Company Addressess, File Download

Appendix A: Company Names and Addresses provides names, addresses, and telephone numbers for companies mentioned in the report.

Price: $150.00

Format
File Download

Quantity:


Email a Friend

 

Download Update 2 FREE!

Download Table of Contents and List of Exhibits FREE

Download Adobe Acrobat Reader


Secure transactions provided by LinkPoint International.

 

Home | Search | Current Order | Saved Cart

 


Scientia Veritas, L.L.P.
5910 Northwood Drive
Evergreen, CO  80439
www.ScientiaVeritas.com
Healthcare:  (303) 674-3732;  Healthcare@ScientiaVeritas.com
Toxicology/Risk Assessment:  (303) 674-8751;  Toxicology@ScientiaVeritas.com
Fax:  (303) 674-8755